vimarsana.com

Page 5 - அடித்தளம் க்கு நுரையீரல் புற்றுநோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lung Cancer Group Hosts Clinical Trial Panel Discussion

Lung Cancer Group Hosts Clinical Trial Panel Discussion The May meeting of the Charlotte Lung Cancer Patient group, LiveLung, will feature three prominent lung cancer specialists: Upal Basu Roy, PhD., MPH, Vice President of Research for LUNGevity Foundation, Andew Ciupek, PhD, Manager of Clinical Research for the GO2Foundation for Lung Cancer, and Justin Favaro, MD, PhD, of Oncology Specialists of Charlotte. The virtual meeting, which is open to the public, will be held Tuesday, May 11, 2021, at 11:30 am via Zoom. Please email lynn@livelung.org for Zoom information. Free

Mount Nittany Health hits high marks for excellence in care | News, Sports, Jobs

Medical Center named a ‘World’s Best Hospital’ by Newsweek Apr 23, 2021 With a focus on delivering compassionate care of the highest quality and safety for every patient, every time, Mount Nittany Health is proud to be nationally recognized with top honors in clinical care, patient safety and overall performance across the health system. Most recently, Mount Nittany Medical Center was named as one of 350 US hospitals and one of just 15 Pennsylvania hospitals honored as a ‘World’s Best Hospital 2021’ by Newsweek Magazine. “The 2,000 hospitals named in this list–which covers 25 countries, including United States, United Kingdom, Germany and Canada –stand out for their consistent excellence, including distinguished physicians, top-notch nursing care and state-of-the-art technology,” said Newsweek Global Editor-in-Chief, Nancy Cooper.

Amgen Launches Biomarker Assist™, a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing

Search jobs 20-Apr-2021 Amgen Launches Biomarker Assist™, a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing Half of All Patients With NSCLC Have Oncogene Mutations, Yet Many Patients Are Not Tested to Screen for Biomarkers Professional Clinical Guidelines Recommend Broad Biomarker Testing for Actionable and Emerging Biomarkers, Including KRAS Biomarker Assist™ May Provide Eligible Patients Savings on Biomarker Testing Amgen (NASDAQ: AMGN) today announced the launch of Biomarker Assist™, a program to help more patients with metastatic (stage IV) non-small cell lung cancer (NSCLC) gain access to biomarker testing. Biomarker testing at the time of diagnosis is a critical first step in getting patients on the right treatment. Through Biomarker Assist™, eligible patients may save on biomarker testing.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.